Related Experiment Video
Updated: Jun 9, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium
Jennifer Schmidt1, Kristin Friebel, Roland Schönherr
1Institute of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany.
Abstract:
Malignant melanoma, characterized by invasive local growth and early formation of metastases, is the most aggressive type of skin cancer. Melanoma inhibitory activity (MIA), secreted by malignant melanoma cells, interacts with the cell adhesion receptors, integrins α(4)β(1) and α(5)β(1), facilitating cell detachment and promoting formation of metastases. In the present study, we demonstrate that MIA secretion is confined to the rear end of migrating cells, while in non-migrating cells MIA accumulates in the actin cortex. MIA protein takes a conventional secretory pathway including coat protein complex I (COPI)- and coat protein complex II (COPII)-dependent protein transport to the cell periphery, where its final release depends on intracellular Ca(2+) ions. Interestingly, the Ca(2+)-activated K(+)-channel, subfamily N, member 4 (KCa3.1), known to be active at the rear end of migrating cells, was found to support MIA secretion. Secretion was diminished by the specific KCa3.1 channel inhibitor TRAM-34 and by expression of dominant-negative mutants of the channel. In summary, we have elucidated the migration-associated transport of MIA protein to the cell rear and also disclosed a new mechanism by which KCa3.1 potassium channels promote cell migration.
Insights
Melanoma inhibitory activity (MIA) aids cancer spread by detaching cells. This study reveals MIA secretion at cell rear, facilitated by KCa3.1 channels, promoting melanoma cell migration and metastasis.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Malignant melanoma is an aggressive skin cancer.
- Melanoma inhibitory activity (MIA) promotes metastasis by interacting with integrins.
- MIA facilitates cell detachment and the formation of metastases.
Purpose of the Study:
- To investigate the secretion pathway and cellular localization of MIA.
- To elucidate the role of intracellular Ca(2+) and KCa3.1 channels in MIA secretion.
- To understand the mechanism by which MIA promotes melanoma cell migration.
Main Methods:
- Immunofluorescence microscopy to visualize MIA localization in migrating and non-migrating cells.
- Analysis of MIA secretion pathway using COPI- and COPII-dependent transport inhibitors.
- Assessment of KCa3.1 channel activity using specific inhibitors (TRAM-34) and dominant-negative mutants.
- Measurement of intracellular Ca(2+) levels during MIA secretion.
Main Results:
- MIA secretion is localized to the rear of migrating melanoma cells.
- MIA accumulates in the actin cortex of non-migrating cells.
- MIA utilizes a conventional secretory pathway involving COPI and COPII.
- Intracellular Ca(2+) ions are crucial for MIA release.
- The KCa3.1 potassium channel supports MIA secretion at the cell rear.
- Inhibition of KCa3.1 channels reduced MIA secretion and cell migration.
Conclusions:
- MIA transport to the cell rear is linked to cell migration.
- KCa3.1 potassium channels play a novel role in promoting melanoma cell migration by regulating MIA secretion.
Related Concept Videos
MAPK Signaling Cascades
Cancer Cell Migration through Invadopodia
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

